Insulin stimulates the growth and tube formation of human microvascular endothelial cells through autocrine vascular endothelial growth factor

Microvascular Research

Volumn 57, Issue 3, 1999, Pages 329-339

  Yamagishi, Sho ichi ^a   Kawakami, Takuhisa ^a   Fujimori, Hideki ^a   Yonekura, Hideto ^a   Tanaka, Nobushige ^a   Yamamoto, Yasuhiko ^a   Urayama, Hiroshi ^a   Watanabe, Yoh ^a   Yamamoto, Hiroshi ^a  

^a KANAZAWA UNIV SCHOOL OF MEDICINE   (Japan)

Author keywords

Angiogenesis; Diabetic retinopathy; Hypoxia; Insulin; PAI 1; VEGF

Indexed keywords

INSULIN; PLASMINOGEN ACTIVATOR INHIBITOR 1; VASCULOTROPIN;

ARTICLE; AUTOCRINE EFFECT; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; DIABETIC RETINOPATHY; DNA SYNTHESIS; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; REGULATORY MECHANISM; RISK FACTOR; THROMBOGENESIS; VASCULAR ENDOTHELIUM;

EID: 0032774564     PISSN: 00262862     EISSN: None     Source Type: Journal    
DOI: 10.1006/mvre.1999.2145     Document Type: Article

References (35)

1. Adamis A. P., Miller J. W., Bernal M. T., D'Amico D. J., Folkman J., Yeo T. K., Yeo K. T. Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy. Am. J. Ophthalmol. 118:1994;445-450.
2. Aiello L. P., Avery R. L., Arrigg P. G., Keyt B. A., Jampel H. D., Shah S. T., Pasquale L. R., Thieme H., Iwamoto M. A., Park J. E., Nguyen H. V., Aiello L. M., Ferrara N., King G. L. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N. Engl. J. Med. 331:1994;1480-1487.
3. Bertrand F., Atfi A., Cadoret A., L'Allemain G., Robin H., Lascols O., Capeau J., Cherqui G. A role of nuclear factor κB in the antiapoptotic function of insulin. J. Biol. Chem. 273:1998;2931-2938.
4. Chua C. C., Hamdy R. C., Chua B. H. Upregulation of vascular endothelial growth factor by angiotensin II in rat heart endothelial cells. Biochim. Biophys. Acta. 1401:1998;187-194.
5. Cines D. B., Pollak E. S., Buck C. A., Loscalzo J., Zimmerman G. A., McEver R. P., Pober J. S., Wick T. M., Konkle B. A., Schwartz B. S., Barnathan E. S., McCrae E. R., Hug B. A., Schmidt A. M., Stern D. M. Endothelial cells in physiology and in pathophysiology of vascular disorders. Blood. 91:1998;3527-3561.
6. Dorchy H. Characterization of early stages of diabetic retinopathy. Diabetes Care. 16:1993;1212-1214.
7. Etingin O. R., Hajjar D. P., Hajjar K. A., Harpel P. C., Nachman R. L. Lipoprotein (a) regulates plasminogen activator inhibitor-1 expression in endothelial cells. J. Biol. Chem. 266:1991;2459-2465.
8. Ferrara N., Houck K. A., Winer J., Jakeman L., Leung D. W. Molecular and biological properties of the vascular endothelial growth factor family of proteins. Endocr. Rev. 13:1992;18-32.
9. Folkman J., Haudenschild C. Angiogenesisin vitro. Nature. 288:1980;551-556.
10. Folkman J., Shing Y. Angiogenesis. J. Biol. Chem. 267:1992;10931-10934.
11. Frank H. J. L., Pardridge W. M., Morris W. L., Rosenfeld R. G., Choi T. B. Binding and internalization of insulin and insulin-like growth factors by isolated brain microvessels. Diabetes. 35:1986;654-661.
12. Grant D. S., Lelkes P. I., Fukuda K., Kleinman H. K. Intercellular mechanisms involved in basement membrane induced blood vessel differentiation in vitro. In Vitro Cell Dev. Biol. 27A:1991;327-336.
13. Hatakeyama H., Miyamori I., Fujita T., Takeda Y., Takeda R., Yamamoto H. Vascular aldosterone. Biosynthesis and link to angiotensin II-induced hypertrophy of vascular smooth muscle cells. J. Biol. Chem. 269:1994;24316-24320.
14. Houck K. A., Ferrara N., Cachianes G., Li B., Leung D. W. The vascular endothelial growth factor family: Identification of a fourth molecular species and characterization of alternative splicing of RNA. Mol. Endocrinol. 5:1991;1806-1814.
15. Juhan-Vague I., Roul C., Alessi M. C., Ardissone J. P., Heim M., Vague P. Increased plasminogen activator inhibitor activity in non insulin dependent diabetic patients - Relationship with plasma insulin. Thromb. Hemostas. 61:1989;370-373.
16. King G. L., Goodman D., Buzney S., Moses A., Kahn R. Receptors and growth-promoting effects of insulin and insulinlike growth factors on cells from bovine retinal capillaries and aorta. J. Clin. Invest. 75:1985;1028-1036.
17. Klein R., Klein B. E. K., Moss S. E., Davis M. D., DeMets D. L. The Wisconsin epidemiologic study of diabetic retinopathy. Arch. Ophthalmol. 102:1984;527-532.
18. Kubota Y., Kleinman H. K., Martin G. R., Lawley T. J. Role of laminin and basement membrane in the morphological differentiation of human endothelial cells into capillary-like structures. J. Cell. Biol. 107:1989;1589-1598.
19. Murata T., Ishibashi T., Khalil A., Hata Y., Yoshikawa H., Inomata H. Vascular endothelial growth factor plays a role in hyperpermeability of diabetic retinal vessels. Ophthalmic. Res. 27:1995;48-52.
20. Nelson R. G., Wolfe J. A., Horton M. B., Pettitt D. J., Bennett P. H., Knowler W. C. Proliferative retinopathy in NIDDM. Incidence and risk factors in Pima Indians. Diabetes. 38:1989;435-440.
21. Nestler J. E., Barlascini C. O., Tetrault G. A., Fratkin M. J., Clore J. N., Blackard W. G. Increased transcapillary escape rate of albumin in nondiabetic men in response to hyperinsulinemia. Diabetes. 39:1990;1212-1217.
22. Nomura M., Yamagishi S., Harada S., Hayashi Y., Yamashima T., Yamashita J., Yamamoto H. Possible participation of autocrine and paracrine vascular endothelial growth factors in hypoxia-induced proliferation of endothelial cells and pericytes. J. Biol. Chem. 270:1995;28316-28324.
23. Reaven G. M. Role of insulin resistance in human disease. Diabetes. 37:1988;1595-1607.
24. Shima D. T., Adamis A. P., Ferrara N., Yeo K. T., Yeo T. K., Allende R., Folkman J., D'Amore P. A. Hypoxic induction of endothelial cell growth factors in retinal cells: Identification and characterization of vascular endothelial growth factor (VEGF) as the mitogen. Mol. Med. 1:1995;182-193.
25. Small M., Kluft C., MacCuish A. C., Lowe G. D. O. Tissue plasminogen activator inhibition in diabetes mellitus. Diabetes Care. 12:1989;655-658.
26. Sone H., Kawakami Y., Okuda Y., Kondo S., Hanatani M., Suzuki H., Yamashita K. Vascular endothelial growth factor is induced by long-term high glucose concentration and up-regulation by acute glucose deprivation in cultured bovine retinal pigmented epithelial cells. Biochem. Biophys. Res. Commun. 221:1996;193-198.
27. N. Engl. J. Med. 329:1993;977-986.
28. Van Ballegooie E., Hooymans J. M. M., Timmerman Z., Reitsma W. D., Sluiter W. J., Schweitzer N. M. J., Doorenbos H. Rapid deterioration of diabetic retinopathy during treatment with continuous subcutaneous insulin infusion. Diabetes Care. 7:1984;236-242.
29. Yamagishi S., Fujimori H., Yonekura H., Yamamoto Y., Yamamoto H. Advanced glycation endproducts inhibit prostacyclin production and induce plasminogen activator inhibitor-1 in human microvascular endothelial cells. Diabetologia. 41:1999;1435-1444.
30. Yamagishi S., Hsu C. C., Kobayashi K., Yamamoto H. Endothelin 1 mediates endothelial cell-dependent proliferation of vascular pericytes. Biochem. Biophys. Res. Commun. 191:1993a;840-846.
31. Yamagishi S., Kobayashi K., Yamamoto H. Vascular pericytes not only regulate growth, but also preserve prostacyclin-producing ability and protect against lipid peroxide-induced injury of co-cultured endothelial cells. Biochem. Biophys. Res. Commun. 190:1993b;418-425.
32. Yamagishi S., Hsu C. C., Taniguchi M., Harada S., Yamamoto Y., Ohsawa K., Kobayashi K., Yamamoto H. Receptor-mediated toxicity to pericytes of advanced glycosylation end products: A possible mechanism of pericyte loss in diabetic microangiopathy. Biochem. Biophys. Res. Commun. 213:1995;681-687.
33. Yamagishi S., Yamamoto Y., Harada S., Hsu C. C., Yamamoto H. Advanced glycosylation end products stimulate the growth but inhibit the prostacyclin-producing ability of endothelial cells through interactions with their receptors. FEBS Lett. 384:1996;103-106.
34. Yamagishi S., Yonekura H., Yamamoto Y., Katsuno K., Sato F., Mita I., Ooka H., Satozawa N., Kawakami T., Nomura M., Yamamoto H. Advanced glycation endproducts-driven angiogenesisin vitro. J. Biol. Chem. 272:1997;8723-8730.
35. Yamamoto Y., Yamagishi S., Hsu C. C., Yamamoto H. Advanced glycosylation end products-receptor interactions stimulate the growth of human pancreatic cancer cells through the induction of platelet-derived growth factor-B. Biochem. Biophys. Res. Commun. 222:1996;700-705.